Meningococcal group B vaccine (Sanofi Pasteur SA) B群脑膜炎球菌疫苗(赛诺菲) 更新于:2024-11-01 概要 基本信息 药物类型 预防性疫苗 别名 Meningococcal-vaccine-group-B-Emergent-BioSolutons、Research programme: meningococcal vaccine group B - Sanofi、meningococcal vaccine group B(Sanofi Pasteur SA)...
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris and in New Y ...
Application Number: 13/842976 Publication Date: 08/29/2013 Filing Date: 03/15/2013 Export Citation: Click for automatic bibliography generation Assignee: SANOFI PASTEUR INC. Primary Class: 424/197.11 International Classes: A61K39/05;A61K39/095;A61K47/48;A61P31/04;A61P43/00;A61P37/00 ...
Application Number: 11/932276 Publication Date: 06/15/2010 Filing Date: 10/31/2007 Export Citation: Click for automatic bibliography generation Assignee: Sanofi Pasteur Limited (Toronto, Ontario, CA) Primary Class: 435/69.7 Other Classes: 424/263.1, 435/69.1, 530/300, 530/350, 536/23.1, ...
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed...
- Institut Pasteur - 28, rue du Docteur Roux, Paris - France : - N° I - 919 le 28 Décembre 1989 - NO I - 1021 Le 27 Décembre 1990 - NO I - 1022 le 27 Décembre 1990 - N° I - 1023 le 27 Décembre 1990 L'invention sera mieux comprise à l'aide des exemples ci-...